| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 33,75% | 22,94% | -21,74% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,93% | 29,81% | -26,39% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 42,81% | 35,92% | -21,18% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | RVI BIOTECNOLOGÍA | 43,96% | 26,52% | -19,54% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 33,31% | 21,72% | -22,82% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,51% | 28,61% | -27,38% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 42,29% | 34,47% | -22,34% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 43,51% | 25,31% | -20,66% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,77% | 29,45% | -26,70% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 43,80% | 26,16% | -19,89% | · |
